Laboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.
Department of Biomedical Molecular Biology, WE14, Ghent University, Ghent, Belgium.
PLoS Negl Trop Dis. 2024 Jul 1;18(7):e0012294. doi: 10.1371/journal.pntd.0012294. eCollection 2024 Jul.
The scarcity of reliable devices for diagnosis of Animal African trypanosomiasis (AAT) presents a limitation to control of the disease. Existing high-sensitivity technologies such as PCR are costly, laborious, time-consuming, complex, and require skilled personnel. Hence, utilisation of most diagnostics for AAT is impracticable in rural areas, where the disease occurs. A more accessible point-of-care test (POCT) capable of detecting cryptic active infection, without relying on expensive equipment, would facilitate AAT detection. In turn, early management, would reduce disease incidence and severity. Today, several ongoing research projects aim at modifying complex immunoassays into POCTs. In this context, we report the development of an antigen (Ag) detection sandwich ELISA prototype for diagnosis of T. congolense infections, which is comprised of nanobody (Nb) and monoclonal antibody (mAb) reagents. The Nb474H used here, originated from a past study. Briefly, the Nb was engineered starting from mRNA of peripheral blood lymphocytes of an alpaca immunized with soluble lysate of Trypanosoma congolense (TC13). T. congolense glycosomal fructose-1,6-bisphosphate aldolase (TcoALD) was discovered as the cognate Ag of Nb474H. In this study, splenocytes were harvested from a mouse immunized with recombinant TcoALD and fused with NS01 cells to generate a hybridoma library. Random screening of the library on TcoALD retrieved a lone binder, designated IgM8A2. Using Nb474H as Ag-capture reagent in combination with the IgM8A2 monoclonal antibody Ag-detection reagent resulted in a tool that effectively detects native TcoALD released during infection by T. congolense parasites. Hitherto, development of POCT for detection of active trypanosome infection is elusive. The Nanobody/Monoclonal Antibody (Nb/mAb) "hybrid" sandwich technology offers prospects for exploration, using the unique specificity of Nb as a key determinant in Ag capturing, while using the versatility of monoclonal Ab to adapt to various detection conditions.
用于诊断动物非洲锥虫病(AAT)的可靠设备稀缺,这对疾病的控制造成了限制。现有的高灵敏度技术,如 PCR,成本高、费力、耗时、复杂,且需要熟练的人员。因此,在疾病发生的农村地区,大多数 AAT 诊断方法都无法实际应用。如果有一种更易于使用的即时检测(POCT)方法能够检测隐匿性活动性感染,而不依赖昂贵的设备,将有助于检测 AAT。反过来,早期管理将降低疾病的发病率和严重程度。目前,有几个正在进行的研究项目旨在将复杂的免疫测定法修改为 POCT。在此背景下,我们报告了一种用于诊断 T. congolense 感染的抗原(Ag)检测夹心 ELISA 原型的开发,该原型由纳米抗体(Nb)和单克隆抗体(mAb)试剂组成。这里使用的 Nb474H 源自过去的一项研究。简而言之,Nb 是从用 T. congolense(TC13)可溶性裂解物免疫的羊驼外周血淋巴细胞的 mRNA 中设计的。T. congolense 糖质体果糖-1,6-二磷酸醛缩酶(TcoALD)被发现是 Nb474H 的同源 Ag。在这项研究中,从用重组 TcoALD 免疫的小鼠中采集脾细胞,并与 NS01 细胞融合以生成杂交瘤文库。在 TcoALD 上对文库进行随机筛选,获得了一种单独的结合物,命名为 IgM8A2。使用 Nb474H 作为 Ag 捕获试剂,结合 IgM8A2 单克隆抗体 Ag 检测试剂,可有效检测到由 T. congolense 寄生虫感染释放的天然 TcoALD。迄今为止,用于检测活动性锥虫感染的 POCT 的开发仍然难以捉摸。纳米抗体/单克隆抗体(Nb/mAb)“杂交”夹心技术提供了探索的前景,利用纳米抗体的独特特异性作为 Ag 捕获的关键决定因素,同时利用单克隆 Ab 的多功能性来适应各种检测条件。